Deep Cholesterol Binding Sites on Mammalian Membrane Proteins


Ion Channels

[Letters refer to subunits as given in the PDB file, followed by the TM helix number; P Pore Helix; Units of E, kcals/mol with molar concentration units]

E Donor Acceptor Local Residues (within 3 Å of a cholesterol –OH group)
Potassium Channels
Two-pore domain TWIK-1 human, 3ukm
-8.3 Chl OH Thr225 [A P2] OG1 Ser224  [A P2] Thr225 [A P2]
-8.2 Chl OH Thr225 [B P2] OG1 Thr117 [A P1] Ser224 [B P2] Thr225 [B P2]
-7.6 Chl OH Leu115  [A P1] O Leu115 [A P1] Ile142 [A2]
Two-pore domain TRAAK in non-conductive down state, human, 3um7
-8.4 Chl OH Thr238 [B P2] OG1 Thr129 [A P1] Thr237 [B P2] Thr238 [B P2]
-8.1 Chl OH Ser45 [B1] OG Tyr42 [B1] Ser45 [B1] Gly46 [B1]
-7.0 Chl OH Thr212 [B3] OG1 Leu207 [B3] Leu211 [B3] Thr212 [B3]
-7.0 Chl OH Leu151 [B2] O Leu151 [B2]
-6.5 Chl OH Leu208 [A3] O Leu208 [A3] Pro213 [A3]
Two-pore domain TRAAK in non-conductive down state in K+, human, 4wff
-6.6 Chl OH Leu236  [A P2] O Leu236  [A P2]
-6.6 Chl OH Leu151 [A2] O Leu151  [A2]
-6.4 Chl OH Ile127 [B P1] O Ile127 [B P1] Ile154 [B2] Phe157 [B2] Gly158 [B2]
-6.4 Chl OH Tyr42 [A1] OH Tyr42 [A1] Phe148 [B2] Tyr149 [B2]
Two-pore domain TRAAK in non-conductive down state in Tl+, human, 4wfh
-9.9 Chl OH Ile127 [B P1] O Ile154 [B2] Gly158  [B2]
-8.5 Chl OH Thr237 [A P2] O Thr237 [A P2] Thr238 [A P2]
Chl OH Thr238 [A P2] OG1
-8.3 Chl OH Leu236 [A P2] O Leu236 [A P2] Thr237 [A P2]
-8 Chl OH Leu151 [A2] O Leu151 [A2]
-6.3 Chl OH Tyr42 [A1] OH Tyr42 [A1] Phe148 [B2] Tyr149 [B2]
-5.9 Chl OH Leu208 [B3] O Leu208 [B3] Pro213 [B3] Trp264 [B4]
Two-pore domain TRAAK in conductive up state in K+, human, 4wfe
6.5 Chl OH Tyr42  [B1] OH Phe148 [A2] Tyr149 [A2] Tyr42 [B1]
-6.1 Chl OH Tyr271 [A4] OH Cys206 [A3] Tyr271 [A4]
Tyr271 [A4] OH Chl OH
Two-pore domain TRAAK in conductive up state in Tl+, human, 4wfg
-6.6 Tyr42 [A1] OH Chl OH Tyr42 [A1] Phe148 [B2] Tyr149 [B2]
-6.3 Chl OH Tyr42 [A1] OH Tyr42 [A1] Phe148 [B2] Tyr149 [B2]
Tyr42 [A1] OH Chl OH
Two-pore domain TRAAK, domain-swapped, closed fenestrations, human, 4i9w
-6.8 Chl OH Tyr42 [A1] OH Tyr42  [A1] Phe148 [B2] Tyr149 [B2]
Two-pore domain TREK-1 up state human, 4twk
-7.5 Chl OH Tyr284 [A4] OH Ile215 [A3] Tyr284 [A4]
-6.1 Chl OH Tyr57 [B1] OH Ile161 [A2] Tyr162 [A2] Leu165 [A2] Tyr57 [B1]
Two-pore domain TREK-1 up state mouse, 5vk5
-6.2 Chl OH Tyr57 [A1] OH Tyr57 [A1] Ile161 [B2] Tyr162 [B2]
-5.9 Chl OH Leu221 [A3] O Leu221 [A3] Pro226 [A1] Trp277 [A4]
Two-pore domain TREK-1 up state mouse, 5vkn
-5.6 Chl OH Tyr284 [A4] OH Cys219 [A3] Tyr284 [A4]
-5.5 Chl OH Leu221 [A3] O Leu221 [A3] Phe222 [A3]
Two-pore domain TREK-1 complex with ML402, mouse, 5vkp
-5.6 Chl OH Leu221 [A3] O Leu221 [A3] Trp277 [A4]
Two-pore domain TREK-2 up state human, 4bw5
-6.6 Chl OH Tyr87 [A1] OH Tyr87 [A1] Leu191 [B2] Tyr192 [B2] Tyr87 [B1]
Two-pore domain TREK-2 down state human (res. 3.8 A), 4xdj
-8.1 Chl OH Thr281 [A P2] OG1 Thr280 [A P2] Thr281 [A P2]
-7.8 Chl OH Ile194 [A2] O Ile194 [A2]
-7.6 Chl OH Leu279 [B P2] O Leu279 [B P2]
Two-pore domain TREK-2 down state, Br-fluoxetine bound, human, 4xdl
-8.2 Chl OH Ile194 [C2] O Ile194 [C2]
-8.2 Chl OH Thr281 [D P2] OG1 Thr280 [D P2] Thr281 [D P2]
Two-pore domain TREK-2 down state, norfluoxetine bound (res 3.6 Å), human, 4xdk
-8.4 Chl OH Ile170 [A P1] O Ile197 [A2] Gly201 [A2]
-8.2 Chl OH Leu279 [B P2]  O Leu279 [B P2] Thr280 [B P2] Thr281 [B P2]
Voltage-gated channel Kv1.2, rat, 3lut
None
Voltage-gated channel Kv1.2, rat, 2a79 
-8.0 Chl OH Thr401 [A6] OG1 Phe334 [A5] Thr401 [A6]
-7.9 Chl OH Thr401 [A6] OG1 Ala397 [A5] Thr401 [A6]
Voltage-gated channel Kv1.2/Kv2.1 paddle chimera [PDB numbering changed to match 2a79], rat, 2r9r
-6.3 Chl OH Thr401 [A6] OG1 Phe334 [A5] Gly338 [A5] Thr401 [A6]
Voltage-gated channel Kv1.2/Kv2.1 paddle chimera [PDB numbering changed to match 2a79] rat, 3lnm
-7.8 Chl OH Thr401 [A6] OG1 Phe334 [A5] Gly338 [A5] Met372 [A P] Thr401 [A6]
Voltage-gated channel Kv1.2/Kv2.1 paddle chimera, inactivated V410W mutant, rat, 5wie
None
Inward-rectifier Kir 2.2 chicken, 3jyc
-6.7 Trp94 [A1] NE1 Chl O Trp94 [A1] Gln141 [A P]
Inward-rectifier Kir 2.2 mutant apo form, 3spj
-9.1 Chl OH Gln141 [A P] O Gln141 [A P] Ser166 [A2] Gly169 [A2] Cys170 [A2]
-7.7 Trp94 [A1] NE1 Chl O Phe90 [A1] Trp94 [A1] Gln141 [A P]
Inward-rectifier Kir 2.2 in complex with PIP2 chicken, 3spi
-7.0 Chl OH Gln141 [A P] O Gln141 [A P] Ser166 [A2] Gly169 [A2] Cys170 [A2]
Inward-rectifier Kir 2.2 mutant in complex with PIP2 chicken, 3spg
None
Inward-rectifier Kir 2.2 mutant in complex with PIP2 chicken, 3sph
None
Inward-rectifier Kir 2.2 in complex with PPA chicken, 3spc
None
Inward-rectifier Kir 2.2 K62W mutant chicken, 5kuk
None
G-protein gated channel, GIRK2 (Kir 3.2) wild type. mouse, 3syo
-7.0 Chl OH Ser181 [A2] OG Ser177 [A2] Gly180 [A2] Ser181 [A2]
G-protein gated channel, GIRK2 (Kir 3.2) D228N mutant. mouse, 3syc
-6.1 Chl OH Tyr102 [A1] OH Tyr102 [A1]
Tyr102 [A1] OH Chl OH
-6.0 Chl OH Glu152 [B P] OE2 Tyr102 [B1] Glu152 [B P]
Tyr102 [B1] OH Chl OH
G-protein gated channel, GIRK2 (Kir 3.2) wild type plus PIP2, mouse, 3sya
-7.2 Chl OH Ser181 [A2] OG Ser177 [A2] Ser181 [A2] Tyr102 [D1]
G-protein gated channel, GIRK2 (Kir 3.2) R201A mutant plus PIP2, mouse, 3syq
-9.1 Chl OH Ser181 [C2] OG Ser177 [C2] Ser181 [C2]
-9.1 Chl OH Glu152 [B P] O Glu152 [B P] Gly180 [B2] 
Chl OH Gly180 [B2] O
-7.9 Chl OH Ser177 [B2] O Ser177 [B2] Gly180 [B2]  Ser181 [B2]
Chl OH Ser181 [B2] OG
-7.5 Chl OH Tyr102 [D1] OH Tyr102 [D1] Asn184 [D2]
Tyr102 [D1] OH Chl OH
G-protein gated channel, GIRK2 (Kir 3.2) plus G-protein subunits. mouse, 4kfm
-9.6 Chl OH Ser181 [F2] OG Ser177  [F2] Ser181  [F2]
-8.9 Chl OH Glu152 [J P] O Glu152 [J P] Gly180 [J2]
Chl OH Glu152 [J P] OE2
-8.5 Chl OH Ser181 [A2] OG Ser181  [A2] Asn184 [J2]
Calcium-activated channel Slo1 (BK) sea slug, 5tj6
-7.5 Chl OH Ser29 [A1] OG Thr26 [A1] Ser29 [A1] Gly30 [A1]
Lysosomal K+-selective channel TMEM175 homolog, marine worm, 5vre
None
Calcium-ion selective Channels
Orai calcium release-activated CRAC channel, Drosophila, 4hkr
-6.8 Chl OH Thr283 [A4] O Thr283 [A4] Leu286 [A4] Ile287 [A4]
Orai calcium release-activated CRAC channel mutant, Drosophila, 4hks
-6.6 Chl OH Thr283 [A4] O Thr283 [A4] Leu286 [A4] Ile287 [A4]
 
Transient Receptor Potential (TRP) Channels
TRPM4 cation channel, apo state, human, 6bcj
None
TRPM4 cation channel, apo state, human, 6bcl
None
TRPM4 cation channel, ATP bound, human, 6bco
None
TRPM4 cation channel, ATP bound, human, 6bcq
None
TRPM4 cation channel, Ca-free, human, 6bqr
None
TRPM4 cation channel, Ca-bound, human, 6bqv
None
TRPML1,  human, 5wj9
-7.8 Chl OH Tyr439 [A5] OH Tyr439 [A5] Ser500 [A6]
-6.9 Chl OH Ser503 [A6] OG Tyr499 [A6] Ser503 [A6]
TRPML3,  marmoset, 5w3s
-7.1 Chl OH Tyr491 [A6] OH Tyr491 [A6] Ile455 [D P]
Tyr491 [A6] OH Chl OH
TRPV1 rat, 3j5p
-7.7 Chl OH Thr550 [A4] OG1 Met547 [A4] Thr550 [A4] Asn551 [A4] 
-7.5 Chl OH Ser483 [A2] OG Ser483 [A2] Gly484 [A2]
Ser483 [A2] OG Chl OH
TRPV1 rat, 5irz
-8.2 Chl OH Ser483 [A2] OG Ser483 [A2] Gly484 [A2]
Ser483 [A2] OG Chl OH
-8.0 Chl OH Thr550 [A4] OG1 Ala546 [A4] Met547 [A4] Thr550 [A4]
TRPV1 complex with DkTx and RTX, rat, 5irx
-8.6 Chl OH Thr550 [A4] OG1 Ala546 [A4] Met547 [A4] Thr550 [A4]
-6.9 Chl OH Ser483 [A2] OG Ser483 [A2] Gly484 [A2]
Ser483 [A2] OG Chl OH Ser483 [A2] Gly484 [A2]
TRPV1 complex with capsaicin, rat, 5is0
-8.7 Chl OH Thr550 [A4] OG1 Ala546 [A4] Met547 [A4] Thr550 [A4]
-6.6 Chl OH Ser483 [A2] OG Ile479 [A2] Val482 [A2] Ser483 [A2]
TRPV6 rat, 5iwk
None
TRPV6 rat, 5wo6
-5.8 Chl OH Thr430 [A3] OG1 Val426 [A3] Ile427 [A3] Thr430 [A3]
TRPV6 rat, 5wo7
-6.3 Chl OH Val498 [A5] O Val498 [A5] Val499 [A5] Gly502 [A5]
TRPV6-Del1, rat, 5wo8
-6.1 Chl OH Thr430 [A3] OG1 Val426 [A3] Ile427 [A3] Thr430 [A3]
TRPV6, plus Ca2+, rat, 5wo9
-7.1 Chl OH Cys462 [A4] O Trp461 [A4] Cys462 [A4] Val464 [A4] Met465 [A4]
Met465 [A4] N Chl OH
PKD2 polycystic kidney disease channel, human, 5t4d
-6.7 Chl OH Thr663 [A6] OG1 Tyr611 [A5] Thr663 [A6]
Tyr611 [A5] OH Chl OH
Glutamate Receptors
GluA2 glutamate receptor (AMPA) apo form A, rat, 4u2p
-9.1 Tyr533 [A1] OH Chl OH Tyr533 [A1] Arg599 [D2]
-8.2 Chl OH Thr609 [A2] OG1 Trp605 [A2] Thr609 [A2]
-7.3 Chl OH Thr609 [A2] OG1 Trp605 [A2] Thr609 [A2]
Trp605 [A2] NE1 Chl OH
GluA2 glutamate receptor (AMPA) with kainate crystal form A, rat, 4u1w
-7.8 Chl OH Thr609 [A2] OG1 Trp605 [A2] Thr609 [A2]
-7.5 Trp605 [A2] NE1 Chl OH Trp605 [A2] Thr609 [A2]
GluA2 glutamate receptor (AMPA) with kainate crystal form B, rat, 4u1x
-7.6 Chl OH Thr609 [A2] OG1 Thr609 [A2]
-6.8 Chl OH Thr609 [A2] OG1 Thr609 [A2] Trp606 [D2]
GluA2 glutamate receptor (AMPA) mutant with toxin etc, rat, 4u5b
-9.2 Tyr533 [C1] OH Chl OH Arg599 [B2] Tyr533 [C1]
-8.3 Chl OH Thr609 [A2] OG1 Trp605 [A2] Thr609 [A2]
Trp605 [A2] NE1 Chl OH
-7.7 Trp605 [A2] NE1 Chl OH Trp605 [A2]
P2X channels
ATP-gated P2X3 channel closed apo state, human, 5svj
-6.9 Chl OH Thr336 [A2] OG1 Gly333 [A2] Thr336 [A2]
ATP-gated P2X3 channel ATP bound open state, human, 5svk
-7.7 Chl OH Ser331[A2] OG Thr330 [A2] Ser331 [A2]
Chl OH Thr330 [A2] OG1
Chl OH Thr330 [A2] O
-6.2 Chl OH Ser36 [A1] OG1 Leu33 [A1] Ser36 [A1] Tyr37 [A1]
ATP-gated P2X3 channel ATP-bound, desensitized state, human, 5svl
-8.9 Chl OH Thr330 [A2] OG1 Thr330 [A2] Ser331 [A2]
-8.9 Chl OH Ser331 [A2] OG Thr330 [A2] Ser331 [A2]
ATP-gated P2X3 channel agonist bound desensitized state, human, 5svm
-11.4 Chl OH Ser331 [A2] OG Ala327 [A2] Thr330 [A2] Ser331 [A2]
Chl OH Thr330 [A2] OG1
ATP-gated P2X3 channel agonist bound desensitized state, human, 5svp
-11.4 Chl OH Ser331 [A2] OG Ala327 [A2] Thr330 [A2] Ser331 [A2]
Chl OH Thr330 [A2] OG1
ATP-gated P2X3 channel competitive antagonist bound closed  state, human, 5svq
None
ATP-gated P2X3 channel competitive antagonist bound  closed state, human, 5svr
-6.6 Chl OH Ser36 [A1] OG Ser36 [A1]
-6.3 Chl OH Thr336 [A2] OG1 Val332 [A2] Gly333 [A2] Thr336 [A2]
ATP-gated P2X4 channel apo  state, zebra fish, 3h9v
None
ATP-gated P2X4 channel apo  closed state, zebra fish, 3i5d
None
ATP-gated P2X4 channel plus CTP open state, zebra fish, 5wzy
-6.9 Chl OH Ala344 [A2] O Ala344 [A2] Ala347 [A2] Leu348 [A2]
ATP-gated P2X4 channel ATP bound open  state, zebra fish, 4dw1
-7.3 Chl OH Gly343 [A2] O Gly343 [A2] Ala344 [A2]
ATP-gated P2X4 channel ATP-free   closed state, zebra fish, 4dw0
None
ATP-gated P2X4 channel ATP bound open state, Gulf Coast tick, 5f1c
None
ATP-gated P2X7 channel plus competitive antagonist, chicken, 5xw6
-8.4 Chl OH Ser326 [B2] OG Thr322 [B2] Ser326 [B2]
-6.6 Chl OH Tyr330 [C2] OH Tyr330 [C2]
-6.5 Chl OH Thr327 [C2] OG1 Thr327 [C2] Ile328 [C2]
Thr327 [C2] OG1 Chl OH
Acid-sensing ion-channel (ASIC), chicken, 4nyk
None
Chloride channels
Bestrophin-1 (BEST1) Ca-activated Cl channel, jungle fowl, 4rdq
-9.5 Chl OH Ala73 [A2] O Asn70 [A2] Ser71 [A2] Ala73 [A2] Glu74 [A2]
Bestrophin-1 (BEST1) Ca-activated Cl channel mutant, jungle fowl, 5t5n
-8.9 Chl OH Ala73 [A2] O Asn70 [A2] Ala73 [A2] Arg255 [A3]
Neurotransmitter-gated ion channels of the Cys-loop receptor family
Glycine receptor complex with strychnine, human, 5cfb
-7.2 Chl OH Ser296 [A3] OG Leu292 [A3] Ser296 [A3]
Glycine receptor complex with AM-3607, human, 5tio
-7.5 Chl OH Ser296 [A3] OG Leu292 [A3] Ser296 [A3]
Glycine receptor, mutant, complex with AM-3607, human, 5tin
-8.3 Chl OH Ser296 [A3] OG Leu292 [A3] Phe293 [A3] Ser296 [A3]
Glycine receptor, complex with Gly and  ivermectin, human, 5vdh
-8.0 Chl OH Ser296 [A3] OG Leu292 [A3] Phe293 [A3] Ser296 [A3]
GABA-A receptor (β3 homopentamer), human, 4cof
-7.5 Chl OH Ser436 [A4] OG Pro432 [A4] Phe435 [A4] Ser436 [A4]
GABA-A receptor (α5 TMD - β3 ECD chimera) with pregnanolone, human, 5o8f
-8.1 Chl OH Ser302 [A3] OG Ala298 [A3] Ser302 [A3]
Ser302 [A3] OG Chl OH
-7.5 Chl OH Thr408 [A4] OG1 Leu405 [A4] Thr408 [A4] Phe409 [A4]
Serotonin 5-HT3 receptor, mouse, 4pir
-7.6 Chl OH Thr445 [A4] OG1 Ala441 [A4] Tyr442 [A4] Thr445 [A4]